✦ LIBER ✦
971 Preliminary results of a randomized study of 1 VS 2 910 MG/M/SQM doses of amifostine in high-RDI cyclophosphamide (CPM)-epirubicin (EDOX) in patients with high risk breast carcinoma
✍ Scribed by C. Cuvier; A. Ardavanis; J.M. Extra; M. Espie; W. Oster; M. Marty
- Book ID
- 116167716
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 109 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.